Key facts
- Kejintaiji New Technology’s last known valuation is $57.2M (Oct 2025).
- It has raised $52.3M; the latest was Later Stage VC ($52.3M) in Oct 2025.
- Notable investors include CAS Star, Chinese Academy of Sciences Holdings, Lanzhou Foci Pharmaceutical.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Kejintaiji New Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Kejintaiji New Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kejintaiji New Technology
Developer and manufacturer of high-energy medical radiation equipment designed for therapeutic and diagnostic applications. The company provides custom electromagnetic and vacuum systems, enabling medical industry and research users with precision engineering and advanced material solutions.
- Sector
- Healthcare
- HQ
- Lanzhou, China
- Founded
- 2002
- Website
- kjtjgs.com/
- Ownership
- Privately Held (backing)
Kejintaiji New Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kejintaiji New Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kejintaiji New Technology in its N-PORT filings yet. We sweep new filings monthly.